Antares Pharma

Antares Pharma

Revenue-generating product focused specialty pharmaceutical company.

HQ location
Minneapolis, United States
Launch date
Enterprise value
$960m
  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor investor

€0.0

round
investor investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
*

$960m

Valuation: $960m

Acquisition
Total Funding000k
Notes (0)
More about Antares Pharma
Made with AI
Edit

Antares Pharma is a specialty pharmaceutical company that merges drug development expertise with proprietary delivery technology to create safe and effective medicines. The company primarily focuses on self-injection pharmaceutical products and technologies, targeting therapeutic areas such as rheumatology, urology, endocrinology, and neurology. Antares Pharma aims to improve dosing accuracy, reduce side effects, and enhance patient compliance and outcomes through innovative therapies. The company serves patients, physicians, partners, and stakeholders by combining pharmaceutical and medical device knowledge to produce optimal treatment options. Antares Pharma operates in the pharmaceutical market and generates revenue through the development, manufacturing, and sale of its proprietary drug delivery systems and pharmaceutical products. The business model is centered on providing specialized drug delivery solutions that meet the needs of its diverse client base, including healthcare providers and patients.

Keywords: specialty pharmaceutical, self-injection, drug delivery, rheumatology, urology, endocrinology, neurology, dosing accuracy, patient compliance, proprietary technology.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo